Importance: Visual outcome after intraocular lens (IOL) implantation in long eyes is considerably affected by IOL power calculation. Various formulas have been designed to achieve an accurate IOL power prediction. However, controversy about the accuracy remains.
Results: Eleven observational studies, involving 4047 eyes, were enrolled. Six formulas for IOL power calculation were compared: Barrett Universal II, Haigis, Holladay 2, SRK/T, Hoffer Q and Holladay 1. The MAE of Barrett Universal II was statistically lower than that of Holladay 2 (mean difference, MD = −0.04D, P = 0.0002), SRK/T (MD = −0.05D, P < 0.00001), Hoffer Q (MD = −0.07D, P < 0.00001) and Holladay 1 (MD = −0.07D, P < 0.00001). Barrett Universal II yielded significantly higher percentage of eyes within AE0.50D of the prediction error than the other formulas. The heterogeneity was minimized through dividing eyes into two groups by the AL of 26 mm.
Conclusions and Relevance:
This study demonstrates the superiority of Barrett Universal II over Holladay 2, SRK/T, Hoffer Q and Holladay 1 in predicting IOL power in long eyes.
INTRODUCTION
Myopia, associated with long axial length (AL), is a global public health problem. The estimated incidence of myopia has been reported between 25 1 and 46.4% 2 in the United States and even higher in some parts of Asia. 3 Cataract surgery is commonly performed on myopic eyes. The primary goal of cataract surgery is the improvement of visual acuity. Therefore, the selection of the intraocular lens (IOL) power calculation formula to achieve the desired post-operative refraction has become increasingly imperative. 4, 5 The IOL power calculation formulas are less accurate in long eyes, which is commonly defined as AL longer than 24.5 mm, [6] [7] [8] [9] presenting a great challenge for cataract surgeons. The inaccuracy of the IOL power calculation in long eyes is mainly due to the lack of precise measurement of AL and corneal power, poor post-operative anterior chamber depth prediction, 10 and improper selection of IOL power calculation formula. 11 Earlier studies suggested SRK/T as the most accurate formula for long eyes, 12 but some studies showed no significant difference in accuracy among the formulas for patients with long AL. [13] [14] [15] [16] More recent studies revealed that formulas including Barrett Universal II, Olsen, Haigis, were more accurate.
8, 17 Terzi 18 suggested that Haigis was significantly more precise than Hoffer Q and Holladay 2. Roessler 9 indicated that Haigis performed better than Holladay 1 and SRK/T. Bang 19 pointed out that Haigis was statistically superior to Holladay 1, Holladay 2, SRK/T and Hoffer Q. The discrepancy between these trials may come from the insufficient sample size. To achieve a more reliable estimate of the accuracy of different IOL power calculation formulas in long eyes, we perform a meta-analysis. Mean absolute errors (MAE) was selected as the primary outcome measure since the positive and negative prediction error could cancel each other out. 20, 21 MAE was the average of the absolute prediction error value, which was back-calculated by subtracting the post-operative actual refractive sphere equivalent from the calculated refractive sphere equivalent generated by each formula. 20 In addition, the percentage of eyes within AE0.50D of prediction error, another widely used indicator of IOL power calculation accuracy, was chosen as the secondary outcome measure. The results of this meta-analysis will provide valuable clinical guidelines for choosing appropriate IOL power calculation formulas in long eyes.
METHODS

Literature search
Two investigators (WQ and JW) conducted the electronic databases search (PubMed, EMBASE, Cochrane Data Base of Systematic Reviews and the Cochrane Central Register of Controlled Trials) up to September 2017 using the search term: (calculat*OR formula*) AND (long axial length* OR myopi* OR long eye*) AND (cataract OR IOL OR intraocular lens). The two investigators independently evaluated the title and abstract of all the studies identified and checked the reference lists of all the included studies that met the eligibility criteria. We contacted the authors to provide original data when necessary.
Inclusion and exclusion criteria
Articles were retained if they met the following inclusion criteria: (i) focused on individuals with ocular AL longer than 24.5 mm; (ii) eyes with refractive lens exchange or uncomplicated cataract surgery with in-the-bag fixated IOL implantation; (iii) used at least two of the selected IOL power calculation formulas (Barrett Universal II, Haigis, Holladay 2, SRK/T, Holladay 1, Hoffer Q); and (iv) measured AL with IOL-master (partial coherence interferometry, PCI). Articles were excluded if they: (i) included patients with a history of corneal refractive surgery or diseases affecting refraction; (ii) included toric, multifocal, piggyback or not in-the-bag fixated IOL implantation; (iii) did not provide MAE data; Figure 1 . Flowchart of trial selection.
(iv) did not apply IOL constant optimizations; and (v) were review articles or discussion papers, conference abstracts or studies done on animals.
Data extraction and quality assessment
Three researchers (WQ, JW and LT) extracted data independently and compared the results. The disagreements were solved by consulting and discussing results with a fourth researcher (LH). We used a modified check-list adapted from the QUADAS-2 tool to assess the quality of evidence. 22 Study characteristics, including sample size, demographic data (age, sex, ALs), the MAE and the percentage of eyes within AE0.50D of prediction error of the formulas, the IOL type and the post-operative refraction time and method, were extracted. We used the MAE, standard deviation (SD) and the percentage of eyes within AE0.50D of prediction error data from the trials directly. If this information was not provided, we calculated the values from the raw data obtained from the trials. If the SD data could not be retrieved from the text, we applied the mean SD of the remaining trials instead. 20 
Statistical analysis
The weighted mean difference (WMD) was used to analyse the MAE between the formulas. The odds ratio (OR) was calculated to estimate the percentage of eyes within AE0.50D of prediction error. The I 2 value was used to assess the statistical heterogeneity. The random-effect model was applied when the I 2 value was greater than 50%, which indicated the existence of substantial heterogeneities among studies; otherwise, the fixed-effect model was used. 23, 24 Sensitivity analysis and subgroup analysis were performed to investigate the possible source of heterogeneity when the I 2 value was greater than 50% and at least five studies were included. Funnel plots and egger's test were performed to evaluate the publication bias and small-study effect. Data pooling was carried out using Review Manager 
RESULTS
A total number of 1607 articles were initially identified by literature search (Fig. 1) . Among them, 1039 records were left after duplicates removal, of which 978 records were removed due to irrelevance. The remaining 61 trials were chosen for full-text evaluation. Among them, 18 studies did not have MAE data, 10 studies included only one of the selected IOL power calculation formulas, 9 studies used ultrasound method to measure AL, 7 studies included eyes with AL shorter than 24.5 mm and the individual qualified data could not be extracted, 6 studies did not apply lens constant optimizations.
Study characteristics
In total, there were 4074 eyes enrolled in the 11 included studies (Table 1) . 8, [12] [13] [14] [15] [16] [17] [18] [25] [26] [27] The sample size ranged from 24 to 1549 eyes. Most of the studies (n = 9) included patients undergoing cataract surgeries, one trial included patients undergoing refractive lens exchange and one trial included patients with unclear intervention.
Methodological quality of included studies
The quality assessment of the included studies was conducted with the modified QUADAS-2 (Fig. 2) . The detailed information of the full assessment was provided in Appendix . For patient selection, four studies did not include the enrolment information, resulting in an unclear risk of bias. For reference standard, eight of the studies performed the subjective refraction to evaluate patient's refractive status after surgery. For index test and flow assessment, 11 and 10 of the studies were of high quality, respectively. 
Outcomes
Mean absolute error
The comparisons of MAE between Barrett Universal II and the other formulas are shown in Figure 3b -f.
There was no significant difference in MAE between Barrett Universal II and Haigis (Fig. 3b, WMD 
Heterogeneity and sensitivity
The I 2 , mean difference and 95% CI are shown in Table 2 . By pairwise comparison, substantial heterogeneity was detected in four pairs and the randomeffect model was applied. The sensitivity analysis showed that I 2 significantly decreased by omitting Haigis 2007 25 in the comparison between Haigis and SRK/T and by omitting Kane 2016 8 in the comparison between Haigis and Holladay 1. 
Subgroup analysis
The heterogeneity was reduced to insignificant when the patients were subgrouped by the AL difference (24.5-26 and >26 mm). Subgroup analysis showed that no significant subgroup difference was existed in the comparison between Haigis and SRK/T and in the comparison between Holladay 2 and Holladay 1. For the comparison between Barrett Universal II and Haigis, the MAE was significantly lower in Barrett Universal II than Haigis when the AL was between 24.5 and 26 mm (Fig. 5a , WMD [95% CI], −0.07D [−0.12D to −0.02D], P = 0.007). However, no statistical difference was detected when the AL was longer than 26 mm. For the comparison between Haigis and Holladay 1, the MAE was significantly lower in Haigis than Holladay 1 when the AL was longer than 26 mm (Fig. 5c , WMD [95% CI], −0.11D [−0.20D to −0.02D], P = 0.02). However, no statistical difference was detected when the AL was between 24.5 and 26 mm.
DISCUSSION
The IOL power calculation inaccuracy in eyes with long AL is well documented. 12, [28] [29] [30] This metaanalysis assessed the predictive efficiency of different IOL power calculation formulas in eyes with long AL by measuring MAE and the percentage of eyes within AE0.50D of prediction error.
To minimize the heterogeneity and bias, the present analysis developed explicit criteria of inclusion and exclusion. We not only excluded the eyes with AL shorter than 24.5 mm but also excluded the trials which perform IOL power calculation without IOL constant optimization. The data from one study 31 examining AL optimization were not included in our analysis because IOL constant optimization was not used. A second study 15 used IOL constant optimization along with AL optimization but only in some of their data. Only such data were included in our analysis from this second study. We also excluded the studies which performed their biometric measurement using ultrasound biometry (UB) devices. There was a significant difference in AL measurement between UB and PCI, [32] [33] [34] especially in extremely long eyes with posterior staphylomas. The fixation needed in PCI enables the measure of visual axis rather than geometrical axis which might be affected by the indentation of the globe. 35 This meta-analysis demonstrated that Barrett Universal II is superior to Holladay 2, SRK/T, Hoffer Q and Holladay 1. For the comparison between Barrett Universal II and Haigis, although there was no significant MAE difference in eyes with AL longer than 24.5 mm, the subgroup analysis indicated that Barrett Universal II performed better than Haigis when the AL was between 24.5 and 26 mm. However, since all the data in the AL 24.5-26 mm subgroup came from only one trial (Kane 2016 8 ), this result must be interpreted with caution. For the subgroup of eyes with AL longer than 26 mm, both Kane 2016 8 and Cooke 2016 14 demonstrated that no significant difference was detected between Barrett Universal II and Haigis.
The newly developed Olsen formula showed potential advantages in predicting IOL power in eyes with long AL. 14, 17, 31 We also performed the meta-analysis on the comparison of Olsen formula with Barrett Universal II and Haigis. The results of the analysis showed that no statistical difference was observed in the comparison between Olsen and Barrett Universal II (Appendix A, I 2 = 0%, mean difference = 0.00D, P = 0.86), and between Olsen and Haigis (Appendix B, I 2 = 0%, mean difference = −0.02D, P = 0.14). Due to the limitation of the included trials and the eyes, it is still difficult to make a conclusion that which formula among the three is the most accurate one in estimating the IOL power in long eyes.
This meta-analysis has several limitations: (i) We did not consider the variability of the patient characteristics, IOL types and refraction methods, which could potentially affect the accuracy of IOL power calculation. (ii) Given that the prediction error is not normally distributed, median absolute error may describe the populations of interest well. However, there are only limited trials provided the median absolute error information. Instead, we chose MAE, also a widely used indicator, to measure the accuracy of the formulas. (iii) ALs of all the included eyes were measured using PCI. The accuracy of IOL power calculation formulas in long eyes with AL measured by UB needs to be further analysed. (iv) Since there are limited trials evaluating the newly-developed Olsen formula, when we compared the accuracy of Olsen with other formulas in this meta-analysis, the statistical power may be insufficient.
The overall evidence indicated that the application of Barrett Universal II formula in the eyes with long AL is promising with the lower MAE and the higher percentage of eyes within AE0.50D of prediction error when compared to Holladay 2, SRK/T, Hoffer Q and Holladay 1. Barrett Universal II tends to perform better than Haigis in eyes with AL between 24.5 and 26 mm, which needs to be validated by a methodologically sound and a sufficiently sized trial.
